- Home
- APA vs RGC Comparison
APA vs RGC Comparison
Compare APA & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APA
- RGC
- Stock Information
- Founded
- APA 1954
- RGC 2014
- Country
- APA United States
- RGC Hong Kong
- Employees
- APA N/A
- RGC N/A
- Industry
- APA Oil & Gas Production
- RGC Medicinal Chemicals and Botanical Products
- Sector
- APA Energy
- RGC Health Care
- Exchange
- APA Nasdaq
- RGC Nasdaq
- Market Cap
- APA 8.1B
- RGC 6.6B
- IPO Year
- APA N/A
- RGC 2021
- Fundamental
- Price
- APA $22.84
- RGC $14.70
- Analyst Decision
- APA Hold
- RGC
- Analyst Count
- APA 18
- RGC 0
- Target Price
- APA $23.72
- RGC N/A
- AVG Volume (30 Days)
- APA 6.2M
- RGC 278.6K
- Earning Date
- APA 11-05-2025
- RGC 10-24-2025
- Dividend Yield
- APA 4.36%
- RGC N/A
- EPS Growth
- APA N/A
- RGC N/A
- EPS
- APA 2.94
- RGC N/A
- Revenue
- APA $9,804,000,000.00
- RGC N/A
- Revenue This Year
- APA N/A
- RGC N/A
- Revenue Next Year
- APA N/A
- RGC N/A
- P/E Ratio
- APA $7.79
- RGC N/A
- Revenue Growth
- APA 11.98
- RGC N/A
- 52 Week Low
- APA $13.58
- RGC $0.09
- 52 Week High
- APA $27.48
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- APA 57.99
- RGC 54.56
- Support Level
- APA $21.57
- RGC $13.06
- Resistance Level
- APA $23.33
- RGC $13.75
- Average True Range (ATR)
- APA 0.89
- RGC 1.14
- MACD
- APA -0.06
- RGC 0.20
- Stochastic Oscillator
- APA 57.08
- RGC 57.47
About APA APA Corporation
APA Corp is an independent exploration and production company. It develops, and produces crude oil, natural gas, and natural gas liquids. The Company's business has oil and gas operations in three geographic areas: the United States (U.S.), Egypt, and offshore the U.K. in the North Sea (North Sea). APA also has active development, exploration, and appraisal operations ongoing in Suriname, as well as exploration interests in Uruguay, Alaska, and other international locations.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.